
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2019-12-30 | James R. Langevin | house | Sale | $15,001 - $50,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net revenues | $275.5M-15.6% | $326.5M-4.9% | $343.4M-18.0% | $418.9M-9.8% | $464.7M |
| Cost of goods sold | $267.9M-5.9% | $284.8M-33.2% | $426.0M-3.8% | $442.7M+27.4% | $347.4M |
| Gross profit (loss) | $7.6M-81.7% | $41.7M+150.4% | -$82.7M-248.1% | -$23.7M | — |
| Research and development expenses | $23.2M-17.5% | $28.1M-28.8% | $39.5M-36.5% | $62.3M-7.0% | $66.9M |
| Selling, general and administrative expenses | $217.8M+28.3% | $169.7M-16.7% | $203.7M-14.9% | $239.5M+14.3% | $209.5M |
| Loss on write-down of assets held for sale | $49.0M | $0-100.0% | $16.6M | — | — |
| Loss from impairment of long-lived assets | $51.3M | $0 | $0 | — | — |
| Restructuring expenses | $0 | $0+100.0% | -$631K | — | — |
| Total operating expenses | $341.3M+72.5% | $197.8M-23.7% | $259.2M-18.7% | $319.0M+9.2% | $292.2M |
| Loss from operations | -$333.6M-113.7% | -$156.1M+54.3% | -$341.9M+0.3% | -$342.8M-95.9% | -$174.9M |
| Interest expense | -$14.0M-242.4% | -$4.1M-3.6% | -$4.0M+0.3% | -$4.0M-8.7% | -$3.6M |
| Remeasurement of warrant liability | $15.1M | $0 | $0 | — | — |
| Remeasurement of derivative liability | -$12.3M | $0 | $0 | — | — |
| Gain on debt restructuring, net of exchange fees | $548.7M | $0 | $0 | — | — |
| Other, net | $15.3M+153210.0% | -$10K-100.1% | $11.6M+2865.7% | -$420K+13.8% | -$487K |
| Total other income (expense), net | $552.7M+13558.1% | -$4.1M-153.6% | $7.7M | — | -$4.1M |
| Income (loss) before taxes | $219.1M+236.7% | -$160.2M+52.1% | -$334.2M | — | — |
| Income tax (benefit) expense | $0+100.0% | -$26K-620.0% | $5K-84.4% | $32K | — |
| Equity in losses of unconsolidated joint venture | $78K+6.8% | $73K-98.1% | $3.9M-79.4% | $18.9M+536.5% | $3.0M |
| Net income (loss) | $219.0M+236.7% | -$160.3M+52.6% | -$338.1M | — | — |
| Less: Earnings allocated to participating securities | -$41.0M | $0 | $0 | — | — |
| Net income (loss) available to common stockholders—basic (in shares) | $178.0M+211.1% | -$160.3M+52.6% | -$338.1M | — | — |
| Net income (loss) per share available to common stockholders—basic (in dollars per share) | $1K+147.3% | -$2K+53.8% | -$5K | — | — |
| Weighted average common shares outstanding—Basic (in shares) | $155.27B+135.2% | $66.00B+2.7% | $64.30B | — | — |
| Net loss per share available to common stockholders—diluted (in dollars per share) | -$2K+24.7% | -$2K+53.8% | -$5K+8.5% | -$6K-99.7% | -$3K |
| Weighted average common shares outstanding—diluted (in shares) | $180.92B+174.1% | $66.00B+2.7% | $64.30B+1.1% | $63.62B+0.7% | $63.17B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Catalyst Watch: Jobs report, Disney drama, Citi event, and Mickey D's crafted beverage push
Should You Buy Beyond Meat (BYND) Stock Before May 6?
Pilgrim's Pride Q1 Earnings Call Highlights
Beyond Meat® to Report First Quarter 2026 Financial Results on May 6, 2026